eamdacademy.org-gyKp-1792216931-n279199728 1792216931 Eurasian Academy of Medicine and Dentistry info@eamdacademy.org Eurasian Academy of Medicine and Dentistry Journal of Applied Pharmaceutical Technologies and Systems J Appl Pharm Technol Syst 3149-9589 2025 4 1 Sanjay Kulkarni Meenal Joshi Rohan Patil Aniket Deshmukh 2025 10.68159/n279199728 https://eamdacademy.org/pub/journal/3/article/n279199728 Tucker EL, Daskin MS. Pharmaceutical supply chain reliability and effects on drug shortages. Comput Ind Eng. 2022;169:108258. van Oorschot KE, Van Wassenhove LN, Jahre M, Selviaridis K, de Vries H. Drug shortages: A systems view of the current state. Decis Sci. 2022;53(6):969-84. Vann Yaroson E, Breen L, Hou J, Sowter J. Examining the impact of resilience strategies in mitigating medicine shortages in the United Kingdom pharmaceutical supply chain. Benchmarking. 2024;31(3):683-706. Stauffer F, Vanhoorne V, Pilcer G, Chavez PF, Rome S, Schubert MA, et al. Raw material variability of an active pharmaceutical ingredient and its relevance for processability in secondary continuous pharmaceutical manufacturing. Eur J Pharm Biopharm. 2018;127:92-103. Stauffer F, Vanhoorne V, Pilcer G, Chavez PF, Vervaet C, De Beer T. Managing API raw material variability in a continuous manufacturing line–Prediction of process robustness. Int J Pharm. 2019;569:118525. Karttunen AP, Wikström H, Tajarobi P, Fransson M, Sparén A, Marucci M, et al. Comparison between integrated continuous direct compression line and batch processing–effect of raw material properties. Eur J Pharm Sci. 2019;133:40-53. Portier C, Vigh T, Di Pretoro G, Leys J, Klingeleers D, De Beer T, et al. Continuous twin screw granulation: impact of microcrystalline cellulose batch-to-batch variability during granulation and drying–a QbD approach. Int J Pharm X. 2021;3:100077. Menditto E, Orlando V, De Rosa G, Minghetti P, Musazzi UM, Cahir C, et al. Patient-centric pharmaceutical drug product design—the impact on medication adherence. Pharmaceutics. 2020;12(1):44. Stegemann S. Patient-centric drug product design in modern drug delivery as an opportunity to increase safety and effectiveness. Expert Opin Drug Deliv. 2018;15(6):619-27. Stevenson J, Poker R, Schoss J, Campbell M, Everitt C, Holly B, et al. Pharmaceutical and biotech industry perspectives on optimizing patient experience and treatment adherence through subcutaneous drug delivery design. Adv Drug Deliv Rev. 2024;209:115322. Grangeia HB, Silva C, Simoes SP, Reis MS. Quality by design in pharmaceutical manufacturing: a systematic review of current status, challenges and future perspectives. Eur J Pharm Biopharm. 2020;147:19-37. Patriarca R, Bergström J, Di Gravio G, Costantino F. Resilience engineering: current status of the research and future challenges. Saf Sci. 2018;102:79-100. Woods DD. The theory of graceful extensibility: basic rules that govern adaptive systems. Environ Syst Decis. 2018;38(4):433-57. Zio E. The future of risk assessment. Reliab Eng Syst Saf. 2018;177:176-90. Jelsch M, Roggo Y, Kleinebudde P, Krumme M. Model predictive control in pharmaceutical continuous manufacturing: a review from a user’s perspective. Eur J Pharm Biopharm. 2021;159:137-42. Su Q, Ganesh S, Moreno M, Bommireddy Y, Gonzalez M, Reklaitis GV, et al. A perspective on Quality-by-Control in pharmaceutical continuous manufacturing. Comput Chem Eng. 2019;125:216-31. Arden NS, Fisher AC, Tyner K, Yu LX, Lee SL, Kopcha M. Industry 4.0 for pharmaceutical manufacturing: preparing for smart factories of the future. Int J Pharm. 2021;602:120554. Vanhoorne V, Vervaet C. Recent progress in continuous manufacturing of oral solid dosage forms. Int J Pharm. 2020;579:119194. Lee WB, Widjaja E, Heng PW, Chan LW. De-risking excipient particle size distribution variability with automated robust mixing: integrating quality by design and process analytical technology. Eur J Pharm Biopharm. 2020;157:9-24. Bhaskar A, Barros FN, Singh R. Development and implementation of an advanced model predictive control system into continuous pharmaceutical tablet compaction process. Int J Pharm. 2017;534(1–2):159-78. Pauli V, Kleinebudde P, Krumme M. Predictive model-based process start-up in pharmaceutical continuous granulation and drying. Pharmaceutics. 2020;12(1):67. Huang YS, Sheriff MZ, Bachawala S, Gonzalez M, Nagy ZK, Reklaitis GV. Evaluation of a combined MHE-NMPC approach to handle plant-model mismatch in a rotary tablet press. Processes. 2021;9(9):1612. Stegemann S, Sheehan L, Rossi A, Barrett A, Paudel A, Crean A, et al. Rational and practical considerations to guide a target product profile for patient-centric drug product development with measurable patient outcomes–a proposed roadmap. Eur J Pharm Biopharm. 2022;177:81-8. Tian G, Koolivand A, Arden NS, Lee S, O’Connor TF. Quality risk assessment and mitigation of pharmaceutical continuous manufacturing using flowsheet modeling approach. Comput Chem Eng. 2019;129:106508. Vargas JM, Nielsen S, Cárdenas V, Gonzalez A, Aymat EY, Almodovar E, et al. Process analytical technology in continuous manufacturing of a commercial pharmaceutical product. Int J Pharm. 2018;538(1–2):167-78. Waeytens R, Van Hauwermeiren D, Grymonpré W, Nopens I, De Beer T. A framework for the in silico assessment of the robustness of an MPC in a CDC line in function of process variability. Int J Pharm. 2024;658:124137. Vega-Zambrano C, Diangelakis NA, Charitopoulos VM. Data-driven model predictive control for continuous pharmaceutical manufacturing. Int J Pharm. 2025;672:125322. Nasr MM, Krumme M, Matsuda Y, Trout BL, Badman C, Mascia S, et al. Regulatory perspectives on continuous pharmaceutical manufacturing: moving from theory to practice. J Pharm Sci. 2017;106(11):3199-206.